期刊文献+

人工肝支持系统治疗重症肝炎的临床观察 被引量:2

Clinical Observation of Patients with Severe Hepatitis Treated by Artificial Livers Support System
下载PDF
导出
摘要 【目的】探讨应用人工肝支持系统治疗重症肝炎的疗效和安全性。【方法】对50例重症肝炎患者应用人工肝方法进行治疗,通过比较治疗前后患者的临床症状,肝功能、电解质、凝血酶原活动度(PTA)、胆碱酯酶(CHE)变化及存活率和不良反应,并与40例病情相似行常规治疗的患者相对照。【结果】人工肝治疗组临床症状明显改善,近期存活率50%,对照组为30.0%。治疗组不良反应10%,血清谷丙转氨酶(ALT)、总胆红素(TBIL)、总胆汁酸(TBA)均较治疗前和对照组明显下降,且有显著差异(P<0.01),PTA、胆固醇(CHOL)、CHE则明显上升(P<0.01)。电解质、血常规两组及治疗前后相比无明显变化。【结论】人工肝支持系统能明显改善重症肝炎患者的临床症状和生化指标,提高存活率,其对重症肝炎是安全有效的。 [Objective]To investigate the curative effect and safety of artificial livers support system (ALSS)in patients with severe hepatitis. [Methods]Fifty patients with severe hepatitis were treated by way of artificial livers support system. The clinical symptoms, liver function,electrolytes, prothrombin activity, cholinesterase,survival rate and the side effects were observed. The control group consists of 40 similar patients treated by the conventional therapy. [Resuhs]In 50 patients with severe hepatitis, after the treatment by artificial livers support system, the clinical symptoms were improved. Survival rate in the treatment group was 50 %, 30.0% in the control group. The side effects in the treatment group was 10%. There were obvious decreases in serum ALT, TBIL,TBA and clearly increases in serum CHE,CHOL, PTA after treatment compared with thai before treatment( P 〈0.01). but there was no obvious change in electrolytes and blood cell after treatment. [Conclusion]Artificial livers support system can obviously improve the clinical symptoms and the biochemical parameters, increase the survival rate. It is effective and safe in severe hepatitis.
出处 《医学临床研究》 CAS 2005年第10期1404-1406,共3页 Journal of Clinical Research
关键词 肝炎 病毒性 人/治疗 生命支持疗法 hepatitis,viral,human/TH life support care
  • 相关文献

参考文献7

二级参考文献9

  • 1叶脉安,沈清瑞,朱兰英,吴培根,郑克立.血浆置换治疗肾移植术后抗皮质激素的加速期排异反应[J].中国急救医学,1996,16(1):21-23. 被引量:14
  • 2[1]Benal W , Wendan J. Acute liver failure, clinical and management. Eur J Gastroenterol Hepatol, 1999, 11:985-990
  • 3[4]Jaeschke H, Fisher MA, L awson JA, et al. Activation ofcaspase 32 (cpp32) - like proteases is essential for TNF- ainduced. hepdtic parenchymal cell apoptosis and nentrophilmediated heerosis in amurine endotoxin shockmadel. J Immmunol, 1998, 160:3480-3486
  • 4[5]Yoshiba M, Inouek, Sekiyamak, etal. Favorable effecf of new artificial liver support on surival ofpatients with fulminant hepatic failure. Artif Organs, 1996, 20: 1169-1172
  • 5顾长海 王宇明.急性肝功能衰竭[M].四川科技出版社,1997.91.
  • 6李兰娟.人工肝[J].中华肝脏病杂志,2000,8(5):308-308.
  • 7中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 8向德栋,张盛,王宇明,陈耀凯.477例重型病毒性肝炎预后影响因素分析[J].第三军医大学学报,2001,23(6):716-717. 被引量:25
  • 9安宝燕,周霞秋,谷瑞瑛,俞红,郭清,谢敬东.血浆置换治疗慢性重型肝炎[J].中华传染病杂志,2002,20(3):152-155. 被引量:37

共引文献14155

同被引文献31

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部